---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Roche

🌎 roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics, founded in 1896 in Basel, Switzerland. The company focuses on advancing science to improve people's lives, with a strong emphasis on personalized healthcare. Roche is the world's largest biotech company, known for its innovative medicines in oncology, immunology, infectious diseases, and diagnostics. The company aims to improve patient access to medical innovations and has been recognized for its sustainability efforts in the pharmaceuticals and biotechnology industry.

---

Roche - Latest News and Updates

• Roche UK partnered with Great Ormond Street Hospital to establish the Clinical Insights Unit, which has been shortlisted for two HSJ Digital Awards for its innovative use of data and analytics.
• Roche and Zealand Pharma have signed a $5.3 billion agreement for treatment development.
• On March 19, 2025, Roche announced a multi-year collaboration with Oxford BioTherapeutics to develop antibody-based cancer treatments.
• Roche, represented by General Manager Deepti Saraf, launched the 'Empower HER' program in partnership with Sarawak Energy to fund breast cancer treatment for financially challenged patients in Sarawak.
• Roche acquired Poseida Therapeutics, indicating interest in allo CAR-T therapies.

• Roche announced its first FDA clearance using Real World Data, marking a significant advancement in diagnostic submissions and patient care.
• Roche and Zealand Pharma signed a collaboration and licensing agreement to jointly develop and commercialize petrelintide for overweight and obese individuals, enhancing Roche's cardiovascular, renal, and metabolic disease portfolio.
• Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID) using their VENTANA DP 600 pathology slide scanners to enhance early detection of rare eye cancers.
• On May 9, 2025, Roche will open its labs to the public during the Industrienacht Regio Basel, showcasing innovations like 3D printing and digital health technologies.
• Roche Sequencing's NGS R&D uses the latest GPU technologies for real-time data processing in next-generation sequencing.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.